Goldman Sachs Group Inc Mirum Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 555,636 shares of MIRM stock, worth $28.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
555,636
Previous 637,967 12.91%
Holding current value
$28.2 Million
Previous $24.9 Million 7.66%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$37.85 - $46.65 $3.12 Million - $3.84 Million
-82,331 Reduced 12.91%
555,636 $23 Million
Q3 2024

Nov 14, 2024
SELL
$33.68 - $44.74 $4.08 Million - $5.42 Million
-121,051 Reduced 15.95%
637,967 $24.9 Million
Q2 2024

Aug 13, 2024
BUY
$23.57 - $34.85 $1.39 Million - $2.05 Million
58,902 Added 8.41%
759,018 $26 Million
Q1 2024

May 15, 2024
BUY
$24.92 - $30.02 $6.08 Million - $7.32 Million
243,798 Added 53.43%
700,116 $17.6 Million
Q4 2023

Feb 13, 2024
BUY
$27.14 - $34.93 $5.85 Million - $7.53 Million
215,542 Added 89.52%
456,318 $13.5 Million
Q3 2023

May 14, 2024
SELL
$24.63 - $32.85 $5.31 Million - $7.08 Million
-215,542 Reduced 47.24%
240,776 $7.61 Million
Q3 2023

Nov 14, 2023
SELL
$24.63 - $32.85 $840,375 - $1.12 Million
-34,120 Reduced 12.41%
240,776 $7.61 Million
Q2 2023

May 14, 2024
SELL
$23.51 - $30.09 $2.76 Million - $3.53 Million
-117,476 Reduced 29.94%
274,896 $7.11 Million
Q2 2023

Aug 14, 2023
SELL
$23.51 - $30.09 $2.76 Million - $3.53 Million
-117,476 Reduced 29.94%
274,896 $7.11 Million
Q1 2023

May 14, 2024
SELL
$19.19 - $24.1 $948,043 - $1.19 Million
-49,403 Reduced 11.18%
392,372 $9.42 Million
Q1 2023

May 11, 2023
SELL
$19.19 - $24.1 $948,043 - $1.19 Million
-49,403 Reduced 11.18%
392,372 $9.42 Million
Q4 2022

May 14, 2024
BUY
$17.59 - $23.83 $3.62 Million - $4.9 Million
205,747 Added 87.17%
441,775 $8.61 Million
Q4 2022

Feb 13, 2023
BUY
$17.59 - $23.83 $3.62 Million - $4.9 Million
205,747 Added 87.17%
441,775 $8.61 Million
Q3 2022

May 14, 2024
BUY
$19.98 - $29.44 $2.28 Million - $3.36 Million
114,220 Added 93.77%
236,028 $4.96 Million
Q3 2022

Nov 10, 2022
BUY
$19.98 - $29.44 $2.28 Million - $3.36 Million
114,220 Added 93.77%
236,028 $4.96 Million
Q2 2022

May 14, 2024
SELL
$18.42 - $27.5 $6.16 Million - $9.2 Million
-334,510 Reduced 73.31%
121,808 $2.37 Million
Q2 2022

Aug 15, 2022
BUY
$18.42 - $27.5 $1.71 Million - $2.56 Million
93,071 Added 323.87%
121,808 $2.37 Million
Q1 2022

May 16, 2022
SELL
$15.5 - $23.93 $194,308 - $299,986
-12,536 Reduced 30.37%
28,737 $633,000
Q4 2021

Feb 14, 2022
BUY
$13.05 - $19.35 $538,612 - $798,632
41,273 New
41,273 $658,000

Others Institutions Holding MIRM

# of Institutions
201
Shares Held
54.7M
Call Options Held
177K
Put Options Held
167K
View Full List

About Mirum Pharmaceuticals, Inc.

MIRM Quotes by TradingView
  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.86B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email